Fundraising FoxCaffeinated Capital — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+19 more
TrueAccord provides digital debt collection focused on restoring financial stability for consumers who have fallen behind.
AI & Machine LearningFintechSaaS
Nadav Samet(Founder)inOhad Samet(Founder)
Co-investorsArbor VenturesAssurant VenturesBoxGroupHomebrewSpider CapitalSummit Peak Ventures+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.